For a change, Rightwriter is 100% right. China is the primary source of both generic drugs and the chemical/biologic ingredients used in drugs manufactured in India, Ireland and of course, the U.S.
While the FDA ostensibly has inspectors at Chinese production facilities, they are limited in both the frequency of inspections and what they are allowed to inspect. At the end of the Obama administration and through the Trump and Biden administrations, there are ongoing efforts to onshore those production efforts, which of course accelerated during Covid. However, it could be another 5 years or longer before those efforts result in “most” of the drugs produced in the U.S. or by U.S./European countries being sourced 100 percent in either the U.S. or Europe.
Menu